Skip to main content
Caplight Logo









Epigenica Biosciences

Epigenica Biosciences

Private
Canoas, Rio Grande do SulHealthcare & Life Scienceshttps://epigenica.com.br/

Last Round

Accelerator

Aug 5, 2025

Total Funding Raised

$1,000

Company Overview

Epigenica Biosciences is a biotechnology company that develops solutions combining epigenetics and artificial intelligence for the diagnosis and treatment of cancer and other chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Healthcare Analytics, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

epigenomics platformhmqChIPmultiplex ChIP-seqhigh-throughput screeningepigenetic analysisbiomarker discoveryChIP-seqepigenetics CROresearch kitsliquid biopsy analysisdrug discovery toolscell-free nucleosome profilingHTSlife science tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epigenica Biosciences Comparables

Compare Epigenica Biosciences with similar companies based on industry and business-model similarity.

Epigenica Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EpiCypher
81%
Epigentek Group Inc.
79%
Active Motif
76%

Epigenica Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 5, 2025
SeedOct 16, 2023

Key People

Founding team and executive leadership

Barbara K.

Chief Executive Officer

Executive Team

Barbara Kunzler

CEO

Executive Team

Epigenica Biosciences Investors

Notable investors and investment history

Epigenica Biosciences investors
InvestorRounds
Banco Regional de Desenvolvimento do Extremo SulAccelerator
Almi Invest ABSeed
ScaleUp Life Science InvestSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 5, 2025

    $1K round from Banco Regional de Desenvolvimento do Extremo Sul

  • Oct 16, 2023

    Seed round raised with Almi Invest AB and ScaleUp Life Science Invest.

Epigenica Biosciences Filings

Explore SEC and related filing metadata, where available.

Epigenica Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Epigenica Biosciences's valuation, stock price, and market status.

Is Epigenica Biosciences a public or private company?

Epigenica Biosciences is a private company.

What is the current stock price of Epigenica Biosciences?

Epigenica Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Epigenica Biosciences worth (valuation)?

Valuation information for Epigenica Biosciences is not publicly available.

Can I buy Epigenica Biosciences stock?

Epigenica Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Epigenica Biosciences's last funding round?

Funding round information for Epigenica Biosciences is not publicly available.

Who are the main investors in Epigenica Biosciences?

Investor information for Epigenica Biosciences is not publicly disclosed.

Will Epigenica Biosciences IPO soon?

No public IPO plans have been announced for Epigenica Biosciences.

How can I track Epigenica Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epigenica Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCanoas, Rio Grande do Sul
Employee Range2
Year Founded2020
Last FundingAug 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?